Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Cash & Equivalents	549.85	545.68	654.47	743.29	659.84	525.11	500.45	594.35	427.65	474.34	296.33	391.57	387.32	405.87	473.15	549.91	454.65	453.88	507.89	285.12
Short-Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61.56	83.21	231.45
Cash & Short-Term Investments	549.85	545.68	654.47	743.29	659.84	525.11	500.45	594.35	427.65	474.34	296.33	391.57	387.32	405.87	473.15	549.91	454.65	515.44	591.11	516.56
Cash Growth (YoY)	-16.67%	3.92%	30.78%	25.06%	54.30%	10.70%	68.89%	51.79%	10.41%	16.87%	-37.37%	-28.79%	-14.81%	-21.26%	-19.96%	6.46%	-21.46%	-18.54%	176.10%	97.07%
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02	0.03	0.03
Other Receivables	34.07	14.39	13.59	24.65	21.91	21.61	46.12	49.17	2.26	2.53	2.6	3.09	3.16	3.05	2.06	2.75	11.64	11.66	11.36	9.06
Receivables	34.07	14.39	13.59	24.65	21.91	21.61	46.12	49.17	2.26	2.53	2.6	3.09	3.16	3.05	2.06	2.75	11.64	11.68	11.4	9.09
Prepaid Expenses	2.88	8.68	11.74	11.74	-	-	2.47	29.6	-	-	-	-	-	-	-	-	-	-	-	-
Restricted Cash	6.66	5.39	5.51	4.59	3.14	3.11	3.08	3.05	1.56	1.78	3.2	3.23	2.26	3.33	1.31	1.28	2.09	1.9	1.52	1.55
Other Current Assets	22.56	29.32	24.25	28.57	29.22	37.34	32.02	38.11	42.72	43.73	41.5	40.25	17.78	18.77	15.61	15.87	13.25	16.98	15.43	7.51
Total Current Assets	616.02	603.46	709.56	812.85	714.11	587.16	584.15	714.27	474.17	522.38	343.62	438.14	410.52	431.02	492.13	569.81	481.62	546	619.46	534.72
Property, Plant & Equipment	152.7	147.07	157.32	169.48	181.24	193.6	204.78	233.21	159.19	156.28	122.22	120.17	120.31	124.67	125.12	121.45	119.5	116.15	104.01	64.73
Long-Term Investments	-	-	-	4.4	4.4	4.4	4.4	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	160.71	160.35	160.17	162.16	162.04	164.27	158.11	148.87	52.06	52.06	52.06	52.06	52.75	60.52	0.8	0.8	0.8	0.8	0.8	0.8
Other Intangible Assets	273.68	282.89	294.07	309.9	322.34	341.32	335.79	335.86	34.09	38.21	33.08	36.44	39.46	42.76	1.32	1.31	1.46	1.23	1.31	1.39
Long-Term Deferred Tax Assets	0.96	0.96	0.96	0.96	0.96	0.96	2	1.93	-	-	-	-	-	-	-	-	-	-	-	-
Other Long-Term Assets	17.65	17.94	17.44	14.39	14.43	10.65	16.01	14.45	6.99	6.94	6.88	6.89	7.78	7.74	8	7.92	8.15	8.33	8.75	8.72
Total Assets	1,222	1,213	1,340	1,474	1,400	1,302	1,305	1,449	726.5	775.86	557.85	653.7	630.83	666.7	627.37	701.29	611.53	672.52	734.32	610.35

Liabilities

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Accounts Payable	16.38	12.67	20.35	18.12	13.94	19.31	25.09	21.61	2.26	3.76	5.12	3.95	4.27	2.09	4.25	4.59	3.89	3.18	4.16	2.82
Accrued Expenses	63.16	54.86	53.2	69.53	72.15	83	55.18	80.28	38.71	31.48	24.89	41.76	17.58	32.87	25.04	30.29	24.87	20.19	19.55	27.67
Current Portion of Long-Term Debt	11.81	9.44	9.27	0.12	8.92	8.75	8.59	0.11	0.07	1.11	0.06	0.04	0.7	0.68	0.66	0.1	0.1	0.09	0.09	0.09
Current Portion of Leases	12.26	13.25	13.09	21.63	11.53	11.73	11.85	22.11	16.38	15.61	6.06	6.12	5.36	5.22	4.44	5.95	5.54	5.24	4.09	-
Current Unearned Revenue	18.97	29.5	32.79	37.61	47.36	39.69	39.65	61.77	49.58	32.2	36.62	36.43	44	73.11	57.76	56.73	46.75	63.78	54.25	10
Other Current Liabilities	0.33	0.17	1.01	0.7	1.21	1.54	1.63	1.59	1.89	1.92	1.18	4.87	22.23	-	-	2.62	1.89	4.17	3.57	6.08
Total Current Liabilities	122.92	119.89	129.7	147.71	155.1	164.03	141.98	187.47	108.89	86.08	73.92	93.17	94.12	113.96	92.15	100.27	83.04	96.65	85.71	46.66
Long-Term Debt	0.09	4.75	7.18	0.19	11.9	14.2	16.45	0.68	1.02	-	1.07	1.1	1.13	1.16	1.18	0.54	0.56	0.59	0.61	0.63
Long-Term Leases	50.54	39.19	42.84	56.02	50.03	53.4	56.02	85.59	73.16	73.16	43.79	43.41	44.3	45.85	46.77	44.42	45.99	47.76	47.32	-
Long-Term Unearned Revenue	120.02	112.82	114.72	114.01	111.2	126.24	129.61	118.77	15.71	29.17	37.39	51.24	51.38	32.44	57.09	70.26	93.91	89.93	107.12	6.67
Long-Term Deferred Tax Liabilities	18.37	18.31	18.28	23.26	23.31	23.78	22.44	16.58	0.17	-	0.53	1.34	1.93	4.34	-	-	-	-	-	-
Other Long-Term Liabilities	3.96	2.7	2.03	2.08	1.03	1.57	4.79	4.73	3	3	-	-	-	-	-	-	-	-	-	13.45
Total Liabilities	315.9	297.67	314.75	343.27	352.58	383.21	371.29	413.82	201.94	191.41	156.7	190.26	192.86	197.74	197.19	215.48	223.5	234.94	240.75	67.41

Shareholders' Equity

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid-In Capital	3,320	3,212	3,192	3,170	2,981	2,681	2,553	2,474	1,777	1,741	1,460	1,431	1,313	1,251	1,135	1,125	970.1	959.39	949.93	943.14
Retained Earnings	-2,444	-2,325	-2,194	-2,076	-1,968	-1,806	-1,634	-1,431	-1,252	-1,157	-1,059	-967.62	-874.63	-781.61	-704.88	-639.56	-582.06	-521.62	-456.06	-400.08
Comprehensive Income & Other	29.63	27.99	26.66	36.72	34.09	43.62	14.15	-7.64	-	-	-	-	-	-	-	-	-	-0.2	-0.31	-0.13
Total Common Equity	905.81	915	1,025	1,131	1,047	919.15	933.95	1,035	524.56	584.45	401.15	463.44	437.97	468.96	430.18	485.81	388.03	437.58	493.57	542.94
Shareholders' Equity	905.81	915	1,025	1,131	1,047	919.15	933.95	1,035	524.56	584.45	401.15	463.44	437.97	468.96	430.18	485.81	388.03	437.58	493.57	542.94
Total Liabilities & Equity	1,222	1,213	1,340	1,474	1,400	1,302	1,305	1,449	726.5	775.86	557.85	653.7	630.83	666.7	627.37	701.29	611.53	672.52	734.32	610.35

Additional Metrics

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Debt	74.7	66.64	72.38	77.97	82.37	88.08	92.91	108.49	90.63	89.88	50.97	50.67	51.48	52.9	53.05	51.01	52.19	53.68	52.11	0.72
Net Cash (Debt)	475.15	479.05	582.1	665.33	577.46	437.04	407.54	485.86	337.02	384.47	245.35	340.89	335.85	352.97	420.09	498.91	402.46	461.75	539	515.84
Net Cash Growth (YoY)	-17.72%	9.61%	42.83%	36.94%	71.34%	13.67%	66.11%	42.52%	0.35%	8.92%	-41.60%	-31.67%	-16.55%	-23.56%	-22.06%	-3.28%	-30.39%	-25.55%	167.36%	106.63%
Net Cash Per Share	0.88	0.90	1.10	1.26	1.29	1.05	1.01	1.45	1.19	1.59	1.04	1.53	1.57	1.75	2.19	2.69	2.32	2.68	3.16	3.05
Filing Date Shares Outstanding	623.37	535.34	529.91	527.4	521.26	434.66	406.92	401.99	286.84	280.97	237.66	234.65	216.62	215.59	192.36	191.23	189.56	173.08	172.01	170.77
Total Common Shares Outstanding	561.07	535.05	530.63	528.18	491.8	432.83	406.41	396.8	286.12	280.97	237.51	234.27	216.31	206.74	192.23	191.02	174.07	172.82	171.08	170.27
Working Capital	493.1	483.58	579.86	665.14	559	423.13	442.16	526.8	365.28	436.29	269.7	344.97	316.4	317.06	399.98	469.55	398.58	449.34	533.75	488.06
Book Value Per Share	1.61	1.71	1.93	2.14	2.13	2.12	2.30	2.61	1.83	2.08	1.69	1.98	2.02	2.27	2.24	2.54	2.23	2.53	2.89	3.19
Tangible Book Value	471.43	471.77	570.53	658.8	562.56	413.56	440.05	550.05	438.41	494.18	316.02	374.94	345.76	365.69	428.06	483.7	385.78	435.55	491.46	540.75
Tangible Book Value Per Share	0.84	0.88	1.08	1.25	1.14	0.96	1.08	1.39	1.53	1.76	1.33	1.60	1.60	1.77	2.23	2.53	2.22	2.52	2.87	3.18
Machinery	-	-	-	121.86	-	-	-	128.29	92.12	86.51	83.6	82.22	80.89	80.44	75.16	67.69	62.7	60.43	56.12	53.08
Construction In Progress	-	-	-	0.51	-	-	-	2.71	1.71	2.8	5.68	3.23	0.42	0.21	5.52	8.75	35.96	31.04	22.01	16.45
Leasehold Improvements	-	-	-	70.78	-	-	-	72.73	47.04	46.78	46.29	45.93	45.79	46.71	42.96	41.87	14.18	14.17	14.01	13.94

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error